Medical Devices & Diagnostics
Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.
342 stocks
| # | Name |
Funds holding | Growth | Growth % |
Fund value |
|
|---|---|---|---|---|---|---|
| 1 |
1
Johnson & Johnson
JNJ
$611B
| 3,813 | -46 | -1% | $249B |
|
| 2 |
2
Abbott
ABT
$181B
| 2,872 | -41 | -1% | $137B |
|
| 3 |
3
Danaher
DHR
$163B
| 2,181 | -22 | -1% | $145B |
|
| 4 |
4
Medtronic
MDT
$122B
| 2,030 | -51 | -2% | $83.5B |
|
| 5 |
5
Stryker
SYK
$112B
| 1,989 | -3 | -0.2% | $100B |
|
| 6 |
6
Intuitive Surgical
ISRG
$151B
| 1,825 | +80 | +5% | $135B |
|
| 7 |
7
Becton Dickinson
BDX
$52.7B
| 1,588 | -17 | -1% | $59.2B |
|
| 8 |
8
DuPont de Nemours
DD
$17.5B
| 1,387 | +52 | +4% | $23.7B |
|
| 9 |
9
Boston Scientific
BSX
$63.7B
| 1,323 | +97 | +8% | $102B |
|
| 10 |
10
Edwards Lifesciences
EW
$49.9B
| 1,297 | +15 | +1% | $45.6B |
|
| 11 |
11
Roper Technologies
ROP
$37.9B
| 1,250 | +10 | +0.8% | $55.9B |
|
| 12 |
12
GE HealthCare
GEHC
$31.9B
| 1,217 | -41 | -3% | $29.1B |
|
| 13 |
13
Agilent Technologies
A
$49.6B
| 1,013 | -2 | -0.2% | $33B |
|
| 14 |
14
Zimmer Biomet
ZBH
$18B
| 1,010 | -4 | -0.4% | $20.2B |
|
| 15 |
15
DexCom
DXCM
$32.6B
| 1,000 | -34 | -3% | $42.4B |
|
| 16 |
16
Solventum
SOLV
$15B
| 905 | +838 | +1,251% | $5.57B |
|
| 17 |
17
Baxter International
BAX
$13.4B
| 881 | -57 | -6% | $15.2B |
|
| 18 |
18
Labcorp
LH
$26.2B
| 855 | -72 | -8% | $15.8B |
|
| 19 |
19
Quest Diagnostics
DGX
$26.2B
| 839 | +20 | +2% | $13.3B |
|
| 20 |
20
ResMed
RMD
$34B
| 773 | +55 | +8% | $16.4B |
|
| 21 |
21
Align Technology
ALGN
$10.5B
| 768 | -50 | -6% | $15.7B |
|
| 22 |
22
Steris
STE
$21.8B
| 747 | +20 | +3% | $20.9B |
|
| 23 |
23
DELISTED
Hologic
HOLX
| 704 | -3 | -0.4% | $16.6B |
|
| 24 |
24
Waters Corp
WAT
$43.7B
| 694 | +4 | +0.6% | $16.5B |
|
| 25 |
25
Alcon
ALC
$32.1B
| 635 | +16 | +3% | $22.4B |
|